Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Early detection and multidisciplinary treatment are crucial for managing Papillon-Lefévre syndrome.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Oral finasteride and topical minoxidil can regrow hair, but finasteride may affect fertility.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Male hair loss is mainly due to thinner hair, not less hair.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

WNT10A mutations often cause ectodermal dysplasias, with males showing more tooth issues than females.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Stem cells in the hair follicle are regulated by their surrounding environment, which is important for hair growth.

Researchers found that hair shedding happens mostly when new hair is growing and involves a unique process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Minoxidil helps hair growth by activating the β-catenin pathway.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Hair shedding is an active process that could be targeted to treat hair loss.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.